Triple-negative breast cancer (TNBC) is an aggressive type of cancer but lacks targeted therapy methods such as hormone therapy due to the low expression of three primary receptors (ER, PR, and HER2). The gene discussed is ESR1; the disease is triple-negative breast carcinoma.